Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shanghai Jiao Tong University Affiliated Sixth People's Hospital | OTHER |
| Shanghai Health and Medical Center | UNKNOWN |
Not provided
Not provided
Not provided
To determine whether an integrated AI decision support can save time and improve accuracy of assessment of obstructive coronary heart disease (CHD), the investigators are conducting a randomized controlled study of AI guided measurements of obstructive CHD probability compared to clinical assessment in preliminary evaluations by physicians.
This is a randomized controlled trial (RCT) evaluating the effectiveness of an AI-based decision support tool in the preliminary assessment of obstructive CHD by physicians. Retrospectively collected medical records of participants with chest pain or dyspnea will be randomly assigned to either guideline group or AI group after baseline assessment:
There are three settings:
Clinical Intuition (baseline assessment) Physicians assess obstructive CHD probability without any external assistance. Assessment relies solely on the physician's clinical judgment and experience.
Guideline-Based Group (Guideline Group) Physicians use a RF-CL table (risk factor weighted clinical likelihood table) to calculate the probability of obstructive CHD.
This approach aligns with current clinical guidelines to assist in decision-making.
AI-Assisted Group (AI Group) Physicians receive CHD probability estimates and diagnostic recommendations from an AI model based on retinal photographs.
The AI tool provides individualized obstructive CHD probabilities, leveraging retinal biomarkers associated with cardiovascular risk.
Primary Objective To evaluate whether AI-guided decision support could improves diagnostic accuracy of obstructive CHD to a greater extent than standard clinical assessments, both compared to clinical intuition.
Secondary Objective To assess whether AI-guided decision support reduces the time required to complete preliminary assessments of obstructive CHD.
Participants, Readers and Randomization Participants: Case records of participants with chest pain or dyspnea, all underwent CT coronary angiography or invasive coronary angiography.
Readers: Physicians performing preliminary evaluations of obstructive CHD patients.
Randomization: Participants and readers will be randomized into one of the groups (RF-CL or AI) after clinical assessment at baseline using block randomization to ensure balanced group sizes.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Guideline-Based Group (Guideline Group) | Active Comparator | Physicians use a RF-CL table (risk factor weighted clinical likelihood table) to calculate the probability of obstructive CHD. This approach aligns with current clinical guidelines to assist in decision-making. |
|
| AI-Assisted Group (AI Group) | Experimental | Physicians receive CHD probability estimates and diagnostic recommendations from an AI model based on retinal photographs. The AI tool provides individualized obstructive CHD probabilities, leveraging retinal biomarkers associated with cardiovascular risk. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physician readers will be assisted with AI-derived probability and diagnosis of obstructive coronary heart disease | Other | Physician readers will be assisted with AI-derived probability and diagnosis of obstructive coronary heart disease. The AI tool provides individualized obstructive CHD probabilities and diagnosis, leveraging retinal biomarkers associated with cardiovascular risk. |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic Accuracy of Participants with Obstructive Coronary Heart Disease | Whether AI-guided decision support improves the diagnostic accuracy of obstructive coronary heart disease (CHD) to a greater extent than standard clinical assessments (RF-CL), both compared to clinical intuition. All participants of the case records had underwent CT angiography or invasive angiography. The diagnostic accuracy, sensitivity and specificity will be compared across groups. | Through study completion, an average of 1 week |
| Measure | Description | Time Frame |
|---|---|---|
| Time Consumed by Physician Readers to Provide the Diagnosis Impression of Obstructive Coronary Heart Disease. | The time consumed by physician readers will be recorded by an algorithm implemented on the website for reading. | Through study completion, an average of 1 week |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tien Yin Wong, PhD | Tsinghua University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tsinghua University | Beijing | Beijing Municipality | 100084 | China | ||
| Shanghai Health and Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Physician readers will be assisted with RF-CL table to calculate the probability of obstructive coronary heart disease | Other | Physicians use a RF-CL table (risk factor weighted clinical likelihood table) to calculate the probability of obstructive CHD. |
|
| Shanghai |
| Shanghai Municipality |
| 200000 |
| China |
| Shanghai Sixth People's Hospital | Shanghai | Shanghai Municipality | 200000 | China |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided